NORTH AMERICA SICKLE CELL DISEASE MARKET ANALYSIS

North America Sickle Cell Disease Market, By Disease Type (Sickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin C Disease), By Drug Type (Hydroxyurea, L-glutamine, Crizanlizumab, Pain-relievers, Voxelotor, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Published In : Oct 2023
Code : CMI4510
Pages :166
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

North America Sickle Cell Disease Market - Key Players

The major players operating in the North America sickle cell disease market include Novartis International AG, Bristol-Myers Squibb Company, Global Blood Therapeutics, Inc., Pfizer Inc., Emmaus Life Sciences, Inc., ADDMEDICA, Sangamo Therapeutics, Inc., Acceleron Pharma, Inc., Agios Pharmaceuticals, Inc., Chiesi Farmaceutici S.p.A., Vertex Pharmaceuticals, Inc., IMARA, Inc., bluebird bio, Inc., CRISPR Therapeutics, Scribe Therapeutics Inc., Fulcrum Therapeutics, Inc., HPC International, Editas Medicine, Inc., Nicox SA, Fera Pharmaceuticals, and Tessera Therapeutics.